Coloplast A/S (OTCMKTS:CLPBY) Sees Unusually-High Trading Volume – Time to Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares saw an uptick in trading volume on Wednesday . 3,648,237 shares were traded during mid-day trading, an increase of 554% from the previous session’s volume of 558,130 shares.The stock last traded at $6.89 and had previously closed at $6.87.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein upgraded Coloplast A/S to a “hold” rating in a research note on Wednesday, January 28th. Three analysts have rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

Coloplast A/S Trading Up 0.4%

The company has a market capitalization of $15.55 billion, a P/E ratio of 25.56, a P/E/G ratio of 0.67 and a beta of 0.33. The company has a 50-day simple moving average of $7.55 and a 200 day simple moving average of $8.46. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.81 and a current ratio of 1.30.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings data on Friday, February 6th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.12 billion. Coloplast A/S had a return on equity of 27.87% and a net margin of 14.35%. Sell-side analysts expect that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.